Low Expression of PAI-2 as a Novel Marker of Portal Vein Tumor Thrombosis and Poor Prognosis in Hepatocellular Carcinoma

Abstract

Plasminogen activator inhibitor (PAI)-2 was previously shown to be less frequently expressed in hepatocellular carcinoma (HCC). The present study was designed to investigate the clinical, pathological, and prognostic significance of PAI-2 expression in HCC. Expression of PAI-2 was detected immunohistochemically for specimens from 78 patients with HCC after… (More)
DOI: 10.1007/s00268-012-1866-8

Topics

6 Figures and Tables

Statistics

0204020162017
Citations per Year

Citation Velocity: 9

Averaging 9 citations per year over the last 2 years.

Learn more about how we calculate this metric in our FAQ.

Cite this paper

@article{Zhou2012LowEO, title={Low Expression of PAI-2 as a Novel Marker of Portal Vein Tumor Thrombosis and Poor Prognosis in Hepatocellular Carcinoma}, author={Li Zhou and Ye Jin and Quan-cai Cui and Ke-min Jin and Weixun Zhou and Bao-cai Xing}, journal={World Journal of Surgery}, year={2012}, volume={37}, pages={608-613} }